Masimo
Yahoo Finance • 2 days ago
Leading Proxy Advisory Firm Glass Lewis Reiterates Recommendation That Masimo Shareholders Vote FOR Both of Politan’s Independent Director Nominees
Glass Lewis States That Politan’s Nominees Represent a "Clear, Reasoned and Compelling Alternative to the Status Quo" Believes Investors Should Have "Little Confidence" in Existing Board’s Ability to Advance Review of Strategic Alternativ... Full story
Yahoo Finance • 3 days ago
Politan Highlights Need for Further Change in Masimo’s Boardroom Ahead of Thursday’s Annual Meeting
Details How Independent Third Parties and the Evidence in Legal Proceedings Have Consistently Refuted Masimo’s "Defensive Rhetoric" and How Company’s Attacks on Politan Continue to "Crumble Under Basic Scrutiny" Shareholders Can Vote for... Full story
Yahoo Finance • 4 days ago
Politan Comments on Masimo’s Latest Attempt to Block a Fair Shareholder Vote
Shareholders Can Vote for Politan’s Independent Nominees, Darlene Solomon and William Jellison, on the WHITE Card and Can Visit www.AdvanceMasimo.com for Further Information NEW YORK, September 15, 2024--(BUSINESS WIRE)--Politan Capital M... Full story
Yahoo Finance • 5 days ago
Masimo Partners with Qualcomm to Develop Next-Generation Smartwatch Reference Platform for Original Equipment Manufacturers
Qualcomm Technologies and Masimo (Photo: Business Wire) Comprehensive Platform Combines Masimo’s Industry-leading Biosensing Capabilities with Snapdragon Wearable Platforms to Expand the Wear OS by Google™ Ecosystem IRVINE, Calif., Septe... Full story
Yahoo Finance • 14 days ago
Politan Provides Update on Why Masimo Shareholders Should Support Urgently Needed Board Change at Company’s 2024 AGM
Sends Letter to Shareholders Reiterating Why Voting for Both Politan’s "Highly Credible and Capable" Nominees Is Essential in Order to Safeguard Shareholder Value and Realize Masimo’s Potential Highlights Key Facts Brought to Light During... Full story
Yahoo Finance • last month
Masimo Corporation (MASI) Faces a Fierce Battle Against Activist Hedge Fund Politan Capital
We recently compiled a list of the Shake-Up Alert: 40 Companies Facing Activist Pressure.In this article, we are going to take a look at where Masimo Corporation (NASDAQ:MASI) stands against the other companies facing activist pressure. T... Full story
Yahoo Finance • 2 months ago
Leading Proxy Advisory Firm ISS Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees
Both Leading Proxy Advisory Firms – ISS and Glass Lewis – Have Now Strongly Validated Politan’s Case for Change and Recommended Shareholders Vote for Darlene Solomon and William Jellison in Order To Provide Urgently Needed Independent Over... Full story
Yahoo Finance • 3 months ago
Masimo Board of Directors Files Definitive Proxy and Issues Letter to Stockholders
Fig. 1 – Masimo Has Historically Traded at a Premium to Select MedTech Peers (Graphic: Business Wire) Fig. 2 – MedTech P/E Multiples Highly Correlated to Organic Revenue Growth (Graphic: Business Wire) Fig. 3 and Fig. 4 (Graphic: Business... Full story
Yahoo Finance • 4 months ago
Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
Masimo Stork™ (Photo: Business Wire) With This Clearance, Stork Provides Continuous Monitoring of Oxygen Saturation, Pulse Rate, and Skin Temperature, with Alarms, for Babies up to 18 Months, at Home, Without a Prescription IRVINE, Calif... Full story
Yahoo Finance • 7 months ago
Masimo Announces the First FDA-cleared "Over-the-Counter" Fingertip Pulse Oximeter
Masimo MightySat® Medical (Photo: Business Wire) Masimo MightySat® Medical Provides Clinically Proven Masimo SET® Pulse Oximetry to Consumers for Medical Use Without a Prescription IRVINE, Calif., February 13, 2024--(BUSINESS WIRE)--Masi... Full story
Yahoo Finance • 8 months ago
Sales of Apple's premium watches banned again by court over blood-oxygen sensor patent dispute
A federal appeals court has decided to revive a U.S. sales ban on Apple's premium watches while it referees a patent dispute revolving around a sensor, raising the specter that the company will pull the devices from stores for the second t... Full story
Yahoo Finance • 8 months ago
UPDATE 1-US court bars Apple Watch imports during appeal over ban
(Adds context from court decision in paragraph 2) By Blake Brittain WASHINGTON, Jan 17 (Reuters) - Apple Watches capable of reading blood-oxygen levels cannot be imported into the U.S. while Apple challenges a government decision that th... Full story
Yahoo Finance • 8 months ago
Apple plans to remove sensor from some watch models depending on how a court rules in patent dispute
Apple is prepared to remove the blood-oxygen sensor from its internet-connected watches if a court doesn’t give it more leeway while it pursues a bid to overturn a ruling that has blocked its use of the technology. A potential redesign of... Full story
Yahoo Finance • 9 months ago
Apple Watch Sales Ban Is Put on Hold by US Appeals Court
(Bloomberg) -- Apple Inc. won a court ruling temporarily pausing a US sales ban on its newest smartwatches, giving the company a reprieve in a patent fight that had forced the devices off the market and threatened an estimated $17 billion... Full story
Yahoo Finance • 9 months ago
Apple Gets Interim Stay on Watch Ban
The tech company wins a temporary reprieve from a U.S. government ban on the sale of some Apple Watch models. Continue reading... Full story
Yahoo Finance • 9 months ago
Apple Wins Temporary Reprieve as U.S. Court Pauses Watch Ban
A U.S. appeals court on Wednesday paused a federal agency’s import ban on most of Apple’s watch models. Continue reading... Full story
Yahoo Finance • 9 months ago
Apple halts online sales of its Apple Watch Series 9 and Apple Watch Ultra 2
Apple (AAPL) has officially halted online sales of its Apple Watch Series 9 and Apple Watch Ultra 2 in the US due to a patent dispute related to their blood oxygen sensors between the tech giant and medical technology company Masimo (MASI)... Full story
Yahoo Finance • 10 months ago
Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use
IRVINE, Calif., November 17, 2023--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter (OTC) and prescription use (Rx). Masimo W1 is the first FDA-... Full story
Yahoo Finance • 10 months ago
Masimo Reports Third Quarter 2023 Financial Results
Third Quarter 2023 Highlights Consolidated revenue was $478.9 million; Healthcare revenue was $307.8 million; Non-healthcare revenue was $171.1 million; GAAP net income per diluted share was $0.20; and Non-GAAP net income per diluted shar... Full story
Yahoo Finance • 11 months ago
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Masimo Corporation (NASDAQ: MASI) on behalf of long-term stockholders... Full story
